Drug Availability, Life Structure, and Situational Ethics of Heroin Addicts

Urban Life ◽  
1987 ◽  
Vol 15 (3-4) ◽  
pp. 395-419 ◽  
Author(s):  
Charles E. Faupel
1974 ◽  
Vol 125 (588) ◽  
pp. 470-471 ◽  
Author(s):  
Letitia R. West ◽  
M. V. Driver

Since the implementation in April 1968 of the 1967 Dangerous Drugs Act, it has been illegal for any doctors except those working in drug centres to prescribe heroin. With the consequent introduction of the methadone maintenance clinics there has been a definite change in the overall pattern of addiction, largely governed by drug availability. It is difficult to estimate the extent of dependence on, or misuse of, barbiturates, but it is likely that the figure for the United Kingdom may be in the order of 150 to 250 per 100,000 (Bewley, 1970). In a recent study of sedative abuse, Mitcheson et al. (1970) found that 95 per cent of the heroin addicts interviewed had used sedatives.


1974 ◽  
Vol 134 (6) ◽  
pp. 1001-1006 ◽  
Author(s):  
S. M. Brown
Keyword(s):  

Author(s):  
Joia S. Mukherjee

Treatment and curative medical care often require medication. This chapter focuses on the provision of medications in impoverished settings and the challenges that inhibit access to life-saving drugs. It will review the failure of the for-profit market to increase drug access for the poor. The evolving concept of essential drugs will be explored by reviewing the history the WHO Essential Medicines List (EML) and the fight to expand the list to include new, and often patented medicines. The international treaties and policies that impact drug availability will be highlighted as will novel systems for drug development and distribution. Finally, the chapter will highlight the growing movement to decrease costs, increase supply, and advance development of drugs for neglected diseases affecting impoverished people.


PLoS ONE ◽  
2012 ◽  
Vol 7 (9) ◽  
pp. e45632 ◽  
Author(s):  
Xuyi Wang ◽  
Linxiang Tan ◽  
Yi Li ◽  
Yao Zhang ◽  
Dongyi Zhou ◽  
...  

Addiction ◽  
1999 ◽  
Vol 94 (4) ◽  
pp. 489-493 ◽  
Author(s):  
Lisa Borg ◽  
Elizabeth Khuri ◽  
Aaron Wells ◽  
Dorothy Melia ◽  
Nora V. Bergasa ◽  
...  

2021 ◽  
Vol 11 (4) ◽  
pp. 1931
Author(s):  
Alessandra Pulliero ◽  
Aldo Profumo ◽  
Camillo Rosano ◽  
Alberto Izzotti ◽  
Sergio Claudio Saccà

The aim of this research was to evaluate the effects of different lens types on the availability and efficacy of anti-inflammatory and antibiotic drugs. Three lens types were examined: (1) nonionic hydrogel lenses; (2) ionic hydrogel lenses; and (3) silicone hydrogel lenses. The lenses were incubated with (a) dexamethasone; (b) betamethasone; (c) bromophenacyl bromide; and (d) chloramphenicol. Drug availability was quantified by gradient HPLC, and chloramphenicol antibacterial activity was quantified by testing the inhibition of Salmonella typhimurium growth on agar. The lens allowing the most abundant passage of betamethasone was the ionic hydrogel lens, followed by the silicone hydrogel lens and nonionic hydrogel lens. The lens allowing the most abundant passage of dexamethasone was the ionic hydrogel lens, but only at 0.5 h and 1 h. Regarding chloramphenicol, the ionic hydrogel lens and silicone hydrogel lens allowed more abundant passage than the nonionic hydrogel lens. These results highlight the relevance of adapting lenses to anti-inflammatory therapy, thus allowing a personalized medical approach.


Sign in / Sign up

Export Citation Format

Share Document